Settlement restores money to Delaware Medicaid


The News Journal

The Delaware Department of Justice has recovered more than $1 million for the Delaware Medicaid program through a settlement with Bristol-Myers Squibb Company and its former subsidiary Apothecon, Inc., Attorney General Beau Biden announced Monday.

The settlement resolves allegations that BMS illegally marketed and priced prescription medication that cost states’ Medicaid programs. The national settlement, involving 43 states, the District of Columbia, and the federal government, totals $389 million plus interest.

Recovered for the Delaware Medicaid program was $1.1 million. Delaware has received $561,712, including restitution of $274,184 for the Delaware Medicaid program and a penalty of $287,528 that will be paid to the state’s general fund. The balance was returned to federal authorities.

BMS was accused of improper practices including reporting inflated prices for prescription drugs; illegally remunerating physicians, health care providers and pharmacies to induce them to purchase its products; promoting the sale and use of the antipsychotic drug Abilify for uses not approved of by the federal Food and Drug Administration; and misreporting sales prices for the antidepressant drug Serzone.

Advertisements

Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s